|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received January 3, 2008
Revised January 8, 2008
Accepted after revision January 11, 2008
1 HHMI, PILM, BCS, MIT and Brown University Medical School
2 HHMI, PCLM, BCS, MIT
* To whom correspondence should be addressed. E-mail: mbear{at}mit.edu.
Metabotropic glutamate receptors (mGluRs) have been implicated in a diverse variety of neuronal functions. Studies reviewed here indicate that exaggerated signaling through mGluR5 can account for multiple cognitive and syndromic features of fragile X syndrome, the most common inherited form of mental retardation and autism. Because a reduction of mGluR5 signaling can reverse fragile X phenotypes, these studies provide a compelling rationale for the use of mGluR5 antagonists for the treatment of Fragile X and related disorders.
This article has been cited by other articles:
![]() |
C. J. McBain New directions in synaptic and network plasticity - a move away from NMDA receptor mediated plasticity J. Physiol., March 15, 2008; 586(6): 1473 - 1474. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |